Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-25-035435

CEO bought 3,315 shares at $15.07 ($49,957)

From the SEC's structured data for this filing

Trades in this filing

Gline Matthew · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-09-18 Purchase : show line 1 in the form +3,315 $15.07 $49,957 17,287,081 D
Open-market purchases · 3,315 sh · avg $15.07 · $49,957
Loading xslF345X05/form4.xml…